AI Could Help Detect Kidney Disease Before Significant Damage Occurs

Kidney disease can progress silently for years. By the time symptoms become obvious, significant damage may already have occurred, making early detection one of the biggest challenges in kidney care.

Researchers from IIT Madras and Christian Medical College, Vellore, are now working on a technology driven approach that could help doctors identify kidney disease earlier and assess it more precisely.

The research team has developed three complementary artificial intelligence tools designed to predict chronic kidney disease risk, analyse kidney CT scans and create detailed three dimensional models of kidneys.

The goal is not to replace doctors, but to provide clinicians with faster, more consistent and patient specific information that can support clinical decision making.

Three AI Tools, Three Different Roles

The first technology is a machine learning model that uses clinical and laboratory information to predict a person’s risk of developing chronic kidney disease.

This could be particularly valuable because early kidney disease may not produce noticeable symptoms. A tool that can identify people at higher risk could potentially help clinicians intervene before the condition progresses further.

The second technology focuses on medical imaging. A deep learning system analyses CT scans and classifies kidneys into four categories: normal kidney, kidney cyst, kidney stone and kidney tumour.

The third tool goes a step further by transforming CT scan information into a three dimensional reconstruction of the kidney. This allows researchers to estimate tumour volume and determine the percentage of the kidney affected by disease.

Together, the three technologies cover different stages of kidney assessment, from predicting disease risk to identifying abnormalities and measuring the extent of a tumour.

Trained on More Than 12,000 CT Images

The CT image classification system has been trained using more than 12,000 images.

The system is designed to distinguish healthy kidneys from kidneys affected by cysts, stones or tumours. Such automated classification could help provide consistent preliminary information to clinicians, particularly in healthcare environments where radiology workloads are high.

However, the technology is still undergoing further validation. The researchers plan to test the models using additional patient datasets and establish stronger collaborations with healthcare institutions before wider real world deployment.

Turning CT Scans Into 3D Kidney Models

One of the most interesting aspects of the project is the three dimensional imaging platform.

Traditional imaging provides doctors with detailed views of an organ, but a patient specific 3D reconstruction can provide another way of understanding the size and extent of a tumour.

The IIT Madras and CMC team developed the framework using open source software, creating a potentially inexpensive and repeatable approach for measuring tumour burden. This information could eventually support treatment planning by helping clinicians understand how much of the kidney is affected.

Why Early Detection Matters

Kidney disease is particularly challenging because patients may not realise that anything is wrong during the early stages.

Delayed detection can allow kidney function to deteriorate before appropriate intervention begins. The researchers believe that earlier identification could help slow disease progression and potentially reduce the need for expensive interventions such as dialysis.

This is where AI could have a meaningful role.

Instead of waiting for disease to become clinically obvious, predictive systems could help identify risk earlier and support doctors in deciding which patients require closer evaluation.

Making AI More Useful for Doctors

An important part of the research is not simply developing accurate algorithms, but making those systems understandable and usable for clinicians.

The chronic kidney disease prediction model has been implemented as a user friendly prototype interface. The researchers are also working on improving its accuracy and interpretability so doctors can better understand and use the predictions in clinical decision making.

This is critical for healthcare AI.

A model that produces a prediction without giving clinicians enough confidence or context may have limited practical value. For AI to become part of routine healthcare, it needs to fit naturally into existing clinical workflows.

From AI Diagnosis to a Kidney Digital Twin

The research could eventually move beyond individual AI tools.

The team sees the project as an important step toward developing a kidney Digital Twin, where AI based image analysis could be combined with patient specific three dimensional anatomical models.

In the longer term, such technology could potentially create virtual representations of a patient’s kidney that help clinicians monitor disease, assess changes and plan personalised treatment.

The researchers are also exploring how these technologies could eventually work alongside wearable sensing systems for longer term kidney health monitoring.

What Happens Next?

Despite the promise, the technology is not yet a substitute for conventional clinical diagnosis.

The researchers plan to expand validation using additional patient datasets and establish partnerships with healthcare institutions for real world deployment. Broader validation will be important to determine how reliably the models perform across different patient populations, hospitals and clinical environments.

The transition from a research prototype to a clinically validated tool requires careful testing, regulatory evaluation and integration into healthcare workflows.

A New Direction for Kidney Care

The collaboration between IIT Madras and CMC Vellore highlights how engineering, artificial intelligence and clinical medicine can come together to address one of healthcare’s most difficult problems: detecting disease before irreversible damage occurs.

The three technologies developed by the team approach the problem from different angles. One predicts chronic kidney disease risk, another analyses CT scans for major kidney abnormalities, and the third creates detailed 3D models to measure tumour involvement.

The bigger vision is even more ambitious.

What if kidney disease could be detected earlier, monitored continuously and managed using a personalised digital model of the patient’s own kidney?

That is the direction in which AI powered kidney care could evolve.